About NeuroLex Diagnostics
NeuroLex Diagnostics is a company based in Atlanta (United States) founded in 2016 was acquired by Sonde Health in August 2020.. NeuroLex Diagnostics has raised $210 thousand across 1 funding round from investors including Sonde Health. NeuroLex Diagnostics offers products and services including SurveyLex and Sonde One. NeuroLex Diagnostics operates in a competitive market with competitors including CVAid, LangAware, KeyWise AI, Novoic and acceXible, among others.
- Headquarter Atlanta, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Neurolex Laboratories, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$210 K (USD)
in 1 rounds
-
Latest Funding Round
$210 K (USD), Seed
Jun 01, 2017
- Investors
-
Employee Count
Employee Count
-
Acquired by
Sonde Health
(Aug 25, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NeuroLex Diagnostics
NeuroLex Diagnostics offers a comprehensive portfolio of products and services, including SurveyLex and Sonde One. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Voice-enabled platform for collecting samples via web browsers.
Tool for companies to ensure safe return to work.
Unlock access to complete
Unlock access to complete
Funding Insights of NeuroLex Diagnostics
NeuroLex Diagnostics has successfully raised a total of $210K through 1 strategic funding round. The most recent funding activity was a Seed round of $210 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $210,000
-
First Round
First Round
(01 Jun 2017)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Seed - NeuroLex Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NeuroLex Diagnostics
NeuroLex Diagnostics has secured backing from 1 investor. Prominent investors backing the company include Sonde Health. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Voice-based platform is utilized for assessing health conditions via biomarkers.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NeuroLex Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - NeuroLex Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Neurolex Diagnostics Comparisons
Competitors of NeuroLex Diagnostics
NeuroLex Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as CVAid, LangAware, KeyWise AI, Novoic and acceXible, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Early stroke diagnosis is enabled by an AI-driven system.
|
|
| domain | founded_year | HQ Location |
AI-driven healthcare technology for detecting cognitive and mental health conditions using speech
|
|
| domain | founded_year | HQ Location |
Provider of AI-based software for the detection of brain disorder
|
|
| domain | founded_year | HQ Location |
Tools for diagnosing brain diseases through speech analysis are developed.
|
|
| domain | founded_year | HQ Location |
Cognitive disease diagnosis tool offered through speech analysis software.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about NeuroLex Diagnostics
When was NeuroLex Diagnostics founded?
NeuroLex Diagnostics was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Where is NeuroLex Diagnostics located?
NeuroLex Diagnostics is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Is NeuroLex Diagnostics a funded company?
NeuroLex Diagnostics is a funded company, having raised a total of $210K across 1 funding round to date. The company's 1st funding round was a Seed of $210K, raised on Jun 01, 2017.
What does NeuroLex Diagnostics do?
NeuroLex Diagnostics was founded in 2016 in Atlanta, United States, within the health technology sector. A speech analysis tool is provided for physicians and patients to identify psychotic and neurological conditions, including depression, schizophrenia, Parkinsons disease, and Alzheimers disease. Machine learning processes audio samples to detect health indicators. Additional services encompass the DepLex assay for depression screening and the AlzLex assay for early Alzheimers symptom identification and memory decline assessment.
Who are the top competitors of NeuroLex Diagnostics?
NeuroLex Diagnostics's top competitors include LangAware, CVAid and KeyWise AI.
What products or services does NeuroLex Diagnostics offer?
NeuroLex Diagnostics offers SurveyLex and Sonde One.
Who are NeuroLex Diagnostics's investors?
NeuroLex Diagnostics has 1 investor. Key investors include Sonde Health.